Cancer Causes & Control

, Volume 16, Issue 2, pp 83–95 | Cite as

The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)

Article

Abstract

In vitro and animal studies indicate that vitamin D may have anti-cancer benefits, including against progression and metastasis, against a wide spectrum of cancers. Supporting an anti-cancer effect of vitamin D is the ability of many cells to convert 25(OH)D, the primary circulating form of vitamin D, into 1,25(OH)2D, the most active form of this vitamin. No epidemiologic studies have directly measured vitamin D concentrations or intakes on risk of total cancer incidence or mortality. However, higher rates of total cancer mortality in regions with less UV-B radiation, and among African-Americans and overweight and obese people, each associated with lower circulating vitamin D, are compatible with a benefit of vitamin D on mortality. In addition, poorer survival from cancer in individuals diagnosed in the months when vitamin D levels are lowest suggests a benefit of vitamin D against late stages of carcinogenesis. The only individual cancer sites that have been examined directly in relation to vitamin D status are colorectal, prostate and breast cancers. For breast cancer, some data are promising for a benefit from vitamin D but are far too sparse to support a conclusion. The evidence that higher 25(OH)D levels through increased sunlight exposure or dietary or supplement intake inhibit colorectal carcinogenesis is substantial. The biologic evidence for an anti-cancer role of 25(OH)D is also strong for prostate cancer, but the epidemiologic data have not been supportive. Although not entirely consistent, some studies suggest that higher circulating 1,25(OH)2D may be more important than 25(OH)D for protection against aggressive, poorly-differentiated prostate cancer. A possible explanation for these divergent results is that unlike colorectal tumors, prostate cancers lose the ability to hydroxylate 25(OH)D to 1,25(OH)2D, and thus may rely on the circulation as the main source of 1,25(OH)2D. The suppression of circulating 1,25(OH)2D levels by calcium intake could explain why higher calcium and milk intakes appear to increase risk of advanced prostate cancer. Given the potential benefits from vitamin D, further research should be a priority.

Keywords

Vitamin D calcium colorectal cancer prostate cancer 25 (OH) vitamin D 

Abbreviations:

25(OH)D

1,25(OH)2D

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Peller, S, Stephenson, CS. 1937Skin irritation and cancer in the United States NavyAm J Med Sci.194326333Google Scholar
  2. 2.
    Apperly, FL. 1941The relation of solar radiation to cancer mortality in North AmericanCancer Res.1191195Google Scholar
  3. 3.
    Garland, CF, Garland, FC. 1980Do sunlight and vitamin D reduce the likelihood of colon cancer?Int J Epidemiol.9227231PubMedGoogle Scholar
  4. 4.
    Garland, FC, Garland, CF, Gorham, ED,  et al. 1990Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiationPrev Med.19614622CrossRefPubMedGoogle Scholar
  5. 5.
    Lefkowitz, ES, Garland, CF. 1994Sunlight, vitamin D, and ovarian cancer mortality rates in US womenInt J Epidemiol2311331136PubMedGoogle Scholar
  6. 6.
    Schwartz, GG, Hulka, BS. 1990Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis)Anticancer Res.1013071311PubMedGoogle Scholar
  7. 7.
    Hanchette, CL, Schwartz, GG. 1992Geographic patterns of prostate cancer mortalityCancer.7028612869PubMedGoogle Scholar
  8. 8.
    Grant, WB. 2002An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiationCancer.9418671875CrossRefPubMedGoogle Scholar
  9. 9.
    Miller, GJ, Stapleton, GE, Ferrara JA, ,  et al. 1992The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3Cancer Res.52515520PubMedGoogle Scholar
  10. 10.
    Lokeshwar, BL, Schwartz, GG, Selzer, MG,  et al. 1999Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089Cancer Epidemiol Biomarkers Prev.8241248PubMedGoogle Scholar
  11. 11.
    Meggouh, F, Lointier, P, Saez, S. 1991Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosaCancer Res.5112271233PubMedGoogle Scholar
  12. 12.
    Giuliano, AR, Franceschi, RT, Wood, RJ 1991Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiationArch Biochem Biophys.285261269CrossRefPubMedGoogle Scholar
  13. 13.
    Zhao, X, Feldman, D. 1993Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cellsEndocrinology.13218081814CrossRefPubMedGoogle Scholar
  14. 14.
    Vandewalle, B, Adenis, A, Hornez, L,  et al. 19941,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissuesCancer Lett.866773CrossRefPubMedGoogle Scholar
  15. 15.
    Schwartz, GG, Hill, CC, Oeler TA, ,  et al. 19951,25-dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivoUrology.46365369CrossRefPubMedGoogle Scholar
  16. 16.
    Konety, BR, Schwartz, GG, Acierno, JS,Jr.,  et al. 1996The role of vitamin D in normal prostate growth and differentiationCell Growth Differ.715631570PubMedGoogle Scholar
  17. 17.
    Lucia, MS, Anzano, MA, Slayter, MV,  et al. 1995Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl) retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostateCancer Res.5556215627PubMedGoogle Scholar
  18. 18.
    Beer, TM, Eilers, KM, Garzotto, M,  et al. 2003Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerJ Clin Oncol.21123128CrossRefPubMedGoogle Scholar
  19. 19.
    Liu, G, Wilding, G, Staab, MJ,  et al. 2003Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancerClin Cancer Res.940774083PubMedGoogle Scholar
  20. 20.
    Gross, C, Stamey, T, Hancock, S,  et al. 1998Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)J Urol.15920352039CrossRefPubMedGoogle Scholar
  21. 21.
    Young, MR, Ihm, J, Lozano, Y,  et al. 1995Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrenceCancer Immunol Immunother.413745CrossRefPubMedGoogle Scholar
  22. 22.
    Metz, RJ, Vellody, K, Patel S, ,  et al. 1996Vitamin D3 and ceramide reduce the invasion of tumor cells through extracellular matrix components by elevating protein phosphatase-2AInvasion Metastasis.162800290Google Scholar
  23. 23.
    Young, MR, Halpin, J, Hussain, R,  et al. 1993Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 alpha, 25-dihydroxyvitamin D3 reduces tumor motility and metastasisInvasion Metastasis.13169177PubMedGoogle Scholar
  24. 24.
    Nakagawa, K, Kawaura, A, Kato, S,  et al. 2004Metastatic growth of lung cancer cells is extremely reduced in vitamin D receptor knockout miceJ Steroid Biochem Mol Biol.8990545547CrossRefGoogle Scholar
  25. 25.
    Barroga, EF, Kadosawa, T, Okumura, M,  et al. 2000Inhibitory effects of 22-oxa-calcitriol and all rans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivoRes Vet Sci.687987CrossRefPubMedGoogle Scholar
  26. 26.
    Evans, SR, Shchepotin, EI, Young, H,  et al. 20001,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis modelInt J Oncol.1612491254PubMedGoogle Scholar
  27. 27.
    Fujioka, T, Hasegawa, M, Ishikura, K,  et al. 1998Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinomaJ Urol.160247251CrossRefPubMedGoogle Scholar
  28. 28.
    Yudoh, K, Matsuno, H, Kimura, T. 19991alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanomaJ Lab Clin Med.133120128CrossRefPubMedGoogle Scholar
  29. 29.
    Albert, DM, Marcus, DM, Gallo, JP,  et al. 1992The antineoplastic effect of vitamin D in transgenic mice with retinoblastomaInvest Ophthalmol Vis Sci.3323542364PubMedGoogle Scholar
  30. 30.
    Sundaram, S, Sea, A, Feldman, S,  et al. 2003The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude miceClin Cancer Res.923502356PubMedGoogle Scholar
  31. 31.
    Hollis, BW, Kamerud, JW, Selvaag, SR,  et al. 1993Determination of vitamin D status by radioimmunoassay using I125-labelled tracerClin Chem.39529533PubMedGoogle Scholar
  32. 32.
    Fraser, DR 1980Regulation of the metabolism of vitamin DPhysiol Rev.60551613PubMedGoogle Scholar
  33. 33.
    Barger-Lux, MJ, Heaney, RP, Lanspa, SJ,  et al. 1995An investigation of sources of variation in calcium absorption efficiencyJ Clin Endocrinol Metab80406411CrossRefPubMedGoogle Scholar
  34. 34.
    Young, MV, Schwartz, GG, Wang, L,  et al. 2004The prostate 25-hydroxyvitamin D-1alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin DCarcinogenesis.25967971CrossRefPubMedGoogle Scholar
  35. 35.
    Giovannucci, E. 1998Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesisCancer Causes Control.9567582CrossRefPubMedGoogle Scholar
  36. 36.
    Adams, ND, Gray, RW, Lemann, J,Jr. 1979The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adultsJ Clin Endocrinol Metab4810081016PubMedGoogle Scholar
  37. 37.
    Chan, JM, Stampfer, MJ, Ma, J,  et al. 2001Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study (comment)Am J Clin Nutr.74549554PubMedGoogle Scholar
  38. 38.
    Chan, JM, Pietinen, P, Virtanen M, ,  et al. 2000Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)Cancer Causes Control.11859867CrossRefPubMedGoogle Scholar
  39. 39.
    Holick, MF. 2004Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosisAm J Clin Nutr.79362371PubMedGoogle Scholar
  40. 40.
    Clemens, TL, Adams, JS, Henderson, SL,  et al. 1982Increased skin pigment reduces the capacity of skin to synthesise vitamin D3Lancet.17476CrossRefPubMedGoogle Scholar
  41. 41.
    Nesby-O’Dell, S, Scanlon, KS, Cogswell, ME,  et al. 2002Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994Am J Clin Nutr.76187192PubMedGoogle Scholar
  42. 42.
    Parikh, SJ, Edelman, M, Uwaifo GI, ,  et al. 2004The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adultsJ Clin Endocrinol Metab.8911961199CrossRefPubMedGoogle Scholar
  43. 43.
    Wortsman, J, Matsuoka, LY, Chen, TC,  et al. 2000Decreased bioavailability of vitamin D in obesityAm J Clin Nutr.72690693PubMedGoogle Scholar
  44. 44.
    Feskanich D, Ma J, Fuchs CS , et al. (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (in press)Google Scholar
  45. 45.
    Rohde, CM, Manatt, M, Clagett-Dame, M,  et al. 1999Vitamin A antagonizes the action of vitamin D in ratsJ Nutr.12922462250PubMedGoogle Scholar
  46. 46.
    Johansson, S, Melhus, H. 2001Vitamin A antagonizes calcium response to vitamin D in manJ Bone Miner Res.1618991905PubMedGoogle Scholar
  47. 47.
    Promislow, JH, Goodman-Gruen, D, Slymen, DJ,  et al. 2002Retinol intake and bone mineral density in the elderly: the Rancho Bernardo StudyJ Bone Miner Res.1713491358PubMedGoogle Scholar
  48. 48.
    Melhus, H, Michaelsson, K, Kindmark, A,  et al. 1998Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fractureAnn Intern Med.129770778PubMedGoogle Scholar
  49. 49.
    Feskanich, D, Singh, V, Willett, WC,  et al. 2002Vitamin A intake and hip fractures among postmenopausal womenJAMA.2874754CrossRefPubMedGoogle Scholar
  50. 50.
    Michaelsson, K, Lithell, H, Vessby, B,  et al. 2003Serum retinol levels and the risk of fractureN Engl J Med.348287294CrossRefPubMedGoogle Scholar
  51. 51.
    Grant, WB. 2003Ecologic studies of solar UV-B radiation and cancer mortality ratesRecent Results Cancer Res.164371377PubMedGoogle Scholar
  52. 52.
    Robsahm, TE, Tretli, S, Dahlback, A,  et al. 2004Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway)Cancer Causes Control.15149158CrossRefPubMedGoogle Scholar
  53. 53.
    Calle, EE, Rodriguez, C, Walker-Thurmond, K,  et al. 2003Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adultsN Engl J Med.34816251638CrossRefPubMedGoogle Scholar
  54. 54.
    Meyerhardt, JA, Catalano, PJ, Haller, DG,  et al. 2003Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinomaCancer.98484495CrossRefPubMedGoogle Scholar
  55. 55.
    Petrelli, JM, Calle, EE, Rodriguez, C,  et al. 2002Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US womenCancer Causes Control.13325332CrossRefPubMedGoogle Scholar
  56. 56.
    Rodriguez, C, Patel, AV, Calle, EE,  et al. 2001Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United StatesCancer Epidemiol Biomarkers Prev.10345353PubMedGoogle Scholar
  57. 57.
    Freedland, SJ, Aronson, WJ, CJ, CJ,  et al. 2004Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the shared equal access regional cancer hospital database study groupJ Clin Oncol.22446453CrossRefPubMedGoogle Scholar
  58. 58.
    American Cancer Society2003Cancer Facts and Figures for African Americans, 2003–2004American Cancer SocietyAtlanta, GAGoogle Scholar
  59. 59.
    Aziz, H, Hussain, F, Sohn C, ,  et al. 1999Early onset of breast carcinoma in African American women with poor prognostic factorsAm J Clin Oncol.22436440CrossRefPubMedGoogle Scholar
  60. 60.
    Uitterlinden, AG, Fang, Y, Van Meurs, JB,  et al. 2004Vitamin D receptor gene polymorphisms in relation to vitamin D related disease statesJ Steroid Biochem Mol Biol.89187193CrossRefGoogle Scholar
  61. 61.
    Freedman, DM, Dosemeci, M, McGlynn, K 2002Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control studyOccup Environ Med.59257262CrossRefPubMedGoogle Scholar
  62. 62.
    Laden, F, Spiegelman, D, Neas, LM.,  et al. 1997Geographic variation in breast cancer incidence rates in a cohort of US womenJ Natl Cancer Inst.8913731378CrossRefPubMedGoogle Scholar
  63. 63.
    John, EM, Schwartz, GG, Dreon, DM,  et al. 1999Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev.8399406Google Scholar
  64. 64.
    Shin, MH, Holmes, MD, Hankinson, SE,  et al. 2002Intake of dairy products, calcium, and vitamin D and risk of breast cancerJ Natl Cancer Inst9413011310PubMedGoogle Scholar
  65. 65.
    Grant, WB, Garland, CF. 2004A critical review of studies on vitamin D in relation to colorectal cancerNutr Cancer.48115123CrossRefPubMedGoogle Scholar
  66. 66.
    Garland, CF, Comstock, GW, Garland, FC,  et al. 1989Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective studyLancet.211761178CrossRefPubMedGoogle Scholar
  67. 67.
    Tangrea, J, Helzlsouer, K, Pietinen, P,  et al. 1997Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish menCancer Causes Control.8615625CrossRefPubMedGoogle Scholar
  68. 68.
    Levine, AJ, Harper, JM, Ervin, CM,  et al. 2001Serum 25-hydroxyvitamin D, dietary calcium in take, and distal colorectal adenoma riskNutr Cancer.393541CrossRefPubMedGoogle Scholar
  69. 69.
    Peters, U, McGlynn, KA, Chatterjee, N,  et al. 2001Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomasCancer Epidemiol Biomarkers Prev.1012671274PubMedGoogle Scholar
  70. 70.
    Platz, EA, Hankinson, SE, Hollis, BW,  et al. 2000Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectumCancer Epidemiol Biomarkers Prev.910591065PubMedGoogle Scholar
  71. 71.
    Grau, MV, Baron, JA, Sandler, RS,  et al. 2003Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trailJ Natl Cancer Inst.9517651771PubMedGoogle Scholar
  72. 72.
    Braun, MM, Helzlsouer, KJ, Hollis, BW,  et al. 1995Colon cancer and serum vitamin D metabolite levels 10–17 years prior to diagnosisAm J Epidemiol.142608611PubMedGoogle Scholar
  73. 73.
    Peters, U, Hayes, RB, Chatterjee, N,  et al. 2004Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma riskThe prostate, lung, colorectal and ovarian cancer screening project team. Cancer Epidemiol Biomarkers Prev.13546552Google Scholar
  74. 74.
    Garland, C, Shekelle, RB, Barrett-Conner, E,  et al. 1985Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in menLancet.1307309CrossRefPubMedGoogle Scholar
  75. 75.
    Kearney, J, Giovannucci, E, Rimm, EB,  et al. 1996Calcium, vitamin D and dairy foods and the occurrence of colon cancer in menAm J Epidemiol.143907917PubMedGoogle Scholar
  76. 76.
    Bostick, RM, Potter, JD, Sellers TA, ,  et al. 1993Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer in older womenAm J Epidemiol.13713021317PubMedGoogle Scholar
  77. 77.
    Martinez, ME, Giovannucci, EL, Colditz, GA,  et al. 1996Calcium, vitamin D, and the occurrence of colorectal cancer among womenJ Natl Cancer Inst.8813751382PubMedGoogle Scholar
  78. 78.
    Zheng, W, Anderson, KE, Kushi, LH,  et al. 1998A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal womenCancer Epidemiol Biomarkers Prev.7221225PubMedGoogle Scholar
  79. 79.
    Jarvinen, R, Knekt, P, Hakulinen, T,  et al. 2001Prospective study on milk products, calcium and cancers of the colon and rectumEur J Clin Nutr.5510001007CrossRefPubMedGoogle Scholar
  80. 80.
    McCullough, ML, Robertson, AS, Rodriguez, C,  et al. 2003Calcium, vitamin D, dairy products, and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States)Cancer Causes Control.14112CrossRefPubMedGoogle Scholar
  81. 81.
    Heilbrun, LK, Nomura, A, Hankin, JH,  et al. 1985Dietary vitamin D and calcium and risk of colorectal cancer (letter)Lancet.1925CrossRefGoogle Scholar
  82. 82.
    Benito, E, Stiggelbout, A, Bosch, FX,  et al. 1991Nutritional factors in colorectal cancer risk: a case-control study in MajorcaInt J Cancer.49161167PubMedGoogle Scholar
  83. 83.
    Peters, RK, Pike, MC, Garabrandt, D,  et al. 1992Diet and colon cancer in Los Angeles County, CaliforniaCancer Causes Control.3457473CrossRefPubMedGoogle Scholar
  84. 84.
    Ferraroni, M, La Vecchia, C, D’Avanzo, B,  et al. 1994Selected micronutrient intake and the risk of colorectal cancerBr J Cancer.7011501155PubMedGoogle Scholar
  85. 85.
    Boutron, MC, Faivre, J, Marteau, P,  et al. 1996Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case-control studyBr J Cancer.74145151PubMedGoogle Scholar
  86. 86.
    Pritchard, RS, A., , BJ, , Gerhardssonde Verdier, M 1996Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, SwedenCancer Epidemiol Biomarkers Prev.5897900PubMedGoogle Scholar
  87. 87.
    Marcus, PM, Newcomb, PA. 1998The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin womenInt J Epidemiol.27788793CrossRefPubMedGoogle Scholar
  88. 88.
    Kampman, E, Slattery, ML, Caan, B,  et al. 2000Calcium, vitamin D, sunshine exposures, dairy products and colon cancer risk (United States)Cancer Causes Control.11459466CrossRefPubMedGoogle Scholar
  89. 89.
    Newmark, HL, Wargovich, MJ, Bruce, WR. 1984Colon cancer and dietary fat, phosphate, and calcium: a hypothesisJ Natl Cancer Inst.7213231325PubMedGoogle Scholar
  90. 90.
    Norat, T, Riboli, E. 2003Dairy products and colorectal cancerA review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr.57117Google Scholar
  91. 91.
    Pietinen, P, Malila, N, Virtanen, M,  et al. 1999Diet and risk of colorectal cancer in a cohort of Finnish menCancer Causes Control.10387396CrossRefPubMedGoogle Scholar
  92. 92.
    Wu, K, Willett, WC, Fuchs, CS,  et al. 2002Calcium intake and risk of colon cancer in women and menJ Natl Cancer Inst.94437446PubMedGoogle Scholar
  93. 93.
    Cho, E, Smith-Warner, SA, Spiegelman, D,  et al. 2004Dairy foods and calcium and colorectal cancer: a pooled analysis of 10 cohort studiesJ Natl Cancer Inst.9610151022PubMedGoogle Scholar
  94. 94.
    Baron, JA, Beach, M, Mandel, JS,  et al. 1999Calcium supplements for the prevention of colorectal adenomasThe Calcium Polyp Prevention Study Group. N Engl J Med.340101107Google Scholar
  95. 95.
    Faivre J, Bonithon-Kopp C (1999) A randomized trial of calcium and fiber supplementation in the prevention of recurrence of colorectal adenomas. In: American Gastroenterological Association Annual Meeting, pp. A357, Orlando, FLGoogle Scholar
  96. 96.
    Lamprecht, SA, Lipkin, M. 2001Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesisAnn NY Acad Sci.9527387PubMedGoogle Scholar
  97. 97.
    Corder, EH, Guess, HA, Hulka, BS,  et al. 1993Vitamin D and prostate cancer: a prediagnostic study with stored seraCancer Epidemiol Biomarkers Prev.2467472PubMedGoogle Scholar
  98. 98.
    Gann, PH, Ma, J, Hennekens, CH,  et al. 1996Circulating vitamin D metabolites in relation to subsequent development of prostate cancerCancer Epidemiol Biomarkers Prev.5121126PubMedGoogle Scholar
  99. 99.
    Nomura, AM, Stemmermann, GN, Lee, J,  et al. 1998Serum vitamin D metabolite levels and the subsequent development of prostate cancerCancer Causes Control.9425432CrossRefPubMedGoogle Scholar
  100. 100.
    Platz, EA, Leitzmann, MF, Hollis, BW,  et al. 2004Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancerCancer Causes Control.15255265CrossRefPubMedGoogle Scholar
  101. 101.
    Jacobs, ET, Giuliano, AR, Martinessz, ME,  et al. 2004Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancerJ Steroid Biochem Mol Biol.89533537CrossRefGoogle Scholar
  102. 102.
    Ahonen, MH, Tenkanen, L, L, T.,  et al. 2000Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)Cancer Causes Control.11847852CrossRefPubMedGoogle Scholar
  103. 103.
    Tuohimaa, P, Tenkanen, L, Ahonen M, ,  et al. 2004Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countriesInt J Cancer.108104108CrossRefPubMedGoogle Scholar
  104. 104.
    Dubbelman, R, Jonxis, JHP, Muskiet, FAJ,  et al. 1993Age-dependent vitamin D status and vertebral condition of white women living in Curaçao (The Netherlands Antilles) as compared with their counterparts in The NetherlandsAm J Clin Nutr.58106109PubMedGoogle Scholar
  105. 105.
    Dandona, P, Menon, RK, Shenoy, R,  et al. 1986Low 1,25-dihydroxyvitamin D, secondary hyperparathyroidism, and normal osteocalcin in elderly subjectsJ Clin Endocrinol Metab.63459462PubMedGoogle Scholar
  106. 106.
    Lips, P, Wiersinga, A, Ginkel, FC,  et al. 1988The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjectsJ Clin Endocrinol Metab.67644650PubMedGoogle Scholar
  107. 107.
    Bouillon, RA, Auwerx, JH, Lissens, WD,  et al. 1987Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiencyAm J Clin Nutr.45755763PubMedGoogle Scholar
  108. 108.
    Hegarty, V, Woodhouse, P, Khaw, KT. 1994Seasonal variation in 25-hydroxyvitamin D and parathyroid hormone concentrations in healthy elderly peopleAge Ageing.23478482PubMedGoogle Scholar
  109. 109.
    Luscombe, CJ, Fryer, AA, French, ME,  et al. 2001Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancerLancet.358641642CrossRefPubMedGoogle Scholar
  110. 110.
    Giovannucci, E, Rimm, EB, Wolk, A,  et al. 1998Calcium and fructose intake in relation to risk of prostate cancerCancer Res.58442447PubMedGoogle Scholar
  111. 111.
    Chan, JM, Giovannucci, E, Andersson, S-O,  et al. 1998Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancerCancer Causes Control.9559566CrossRefPubMedGoogle Scholar
  112. 112.
    Kristal, AR, Cohen, JH, Qu, P,  et al. 2002Associations of energy, fat, calcium, and vitamin D with prostate cancer riskCancer Epidemiol Biomarkers Prev.11719725PubMedGoogle Scholar
  113. 113.
    Grant, WB. 1999An ecologic study of dietary links to prostate cancerAltern Med Rev.4162169PubMedGoogle Scholar
  114. 114.
    Armstrong, B, Doll, R 1975Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practicesInt J Cancer.15617631PubMedGoogle Scholar
  115. 115.
    Rose, DP, Boyar, AP, Wynder, EL 1986International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumptionCancer.5822632271Google Scholar
  116. 116.
    Rodriguez, C, McCullough, ML, Mondul, AM,  et al. 2003Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States menCancer Epidemiol Biomarkers Prev.12597603PubMedGoogle Scholar
  117. 117.
    Tseng M, Breslow R, Babb J, et al. (2002). Dairy, calcium, and prostate cancer in the NHANES I Epidemiologic Followup Study cohort. Am J Epidemiol 155: S55Google Scholar
  118. 118.
    Schuurman, AG, Brandt, PA, Dorant, E,  et al. 1999Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort StudyBr J Cancer.8011071113CrossRefPubMedGoogle Scholar
  119. 119.
    Berndt, SI, Carter, HB, Landis, PK,  et al. 2002Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of AgingUrology.6011181123CrossRefPubMedGoogle Scholar
  120. 120.
    Tavani, A, Gallus, S, Franceschi, S,  et al. 2001Calcium, dairy products, and the risk of prostate cancerProstate.48118121CrossRefPubMedGoogle Scholar
  121. 121.
    Hayes, RB, Ziegler, RG, Gridley, G,  et al. 1999Dietary factors and risks for prostate cancer among blacks and whites in the United StatesCancer Epidemiol Biomarkers Prev.82534PubMedGoogle Scholar
  122. 122.
    Tzonou, A, Signorello, LB, Lagiou, P,  et al. 1999Diet and cancer of the prostate: a case-control study in GreeceInt J Cancer.80704708CrossRefPubMedGoogle Scholar
  123. 123.
    Talamini, R, La Vecchia, C, Decarli, A,  et al. 1986Nutrition, social factors, and prostatic cancer in a Northern Italian populationBr J Cancer.53817821PubMedGoogle Scholar
  124. 124.
    Talamini, R, Franceschi, S, La Vecchia, C,  et al. 1992Diet and prostatic cancer: a case-control study in Northern ItalyNutr Cancer.18277286PubMedGoogle Scholar
  125. 125.
    Mettlin, C, Selenskas, S, Natarajan, NS,  et al. 1989Beta-carotene and animal fats and their relationship to prostate cancer risk: a case-control studyCancer.64605612PubMedGoogle Scholar
  126. 126.
    La Vecchia, C, Negri, E, D’Avanzo, B,  et al. 1991Dairy products and the risk of prostatic cancerOncology.48406410PubMedGoogle Scholar
  127. 127.
    Jain, MG, Hislop, GT, Howe, GR,  et al. 1999Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in CanadaNutr Cancer.34173184CrossRefPubMedGoogle Scholar
  128. 128.
    De Stefani, E, Fierro, L, Barrios, E,  et al. 1995Tobacco, alcohol, diet and risk of prostate cancerTumori.81315320PubMedGoogle Scholar
  129. 129.
    Rotkin, ID. 1977Studies in the epidemiology of prostatic cancer: expanded samplingCancer Treat Rep.6117380PubMedGoogle Scholar
  130. 130.
    Schuman, LM, Mandel, JS, Radke, A,  et al. 1982

    Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota case-control study, 1976–1979

    Magnus, K. eds. Trends in Cancer Incidence: Causes and Practical ImplicationsHemisphere Publishing Corp.Washington, DC345354
    Google Scholar
  131. 131.
    Ewings, P, Bowie, C. 1996A case-control study of cancer of the prostate in Somerset and East DevonBr J Cancer.74661666PubMedGoogle Scholar
  132. 132.
    Deneo-Pellegrini, H, Stefani, E, Ronco, A,  et al. 1999Foods, nutrients and prostate cancer: a case-control study in UruguayBr J Cancer.80591597CrossRefPubMedGoogle Scholar
  133. 133.
    Qin, LQ, Xu, JY, Wang, PY,  et al. 2004Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studiesNutr Cancer.482227CrossRefPubMedGoogle Scholar
  134. 134.
    Snowdon, DA, Phillips, RL, Choi, W. 1984Diet, obesity, and risk of fatal prostate cancerAm J Epidemiol.120244250PubMedGoogle Scholar
  135. 135.
    Le Marchand, L, Kolonel, LN, Wilkens, LR,  et al. 1994Animal fat consumption and prostate cancer: a prospective study in HawaiiEpidemiology .5276282PubMedGoogle Scholar
  136. 136.
    Michaud, DS, Augustsson, K, Rimm, EB,  et al. 2001A prospective study on intake of animal products and risk of prostate cancerCancer Causes. Control12557567CrossRefPubMedGoogle Scholar
  137. 137.
    Hsing, AW, McLaughlin, JK, Schuman, LM,  et al. 1990Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort StudyCancer Res.5068366840PubMedGoogle Scholar
  138. 138.
    Mills, PK, Beeson, WL, Phillips, RL,  et al. 1989Cohort study of diet, lifestyle, and prostate cancer in Adventist menCancer.64598604PubMedGoogle Scholar
  139. 139.
    Veierod, MB, Laake, P, Thelle, DS. 1997Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian menInt J Cancer73634638CrossRefPubMedGoogle Scholar
  140. 140.
    Chen, TC, Wang, L, Whitlatch, LW,  et al. 2003Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancerJ Cell Biochem.88315322CrossRefPubMedGoogle Scholar
  141. 141.
    Hsu, JY, Feldman, D, McNeal, JE,  et al. 2001Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibitionCancer Res.6128522856PubMedGoogle Scholar
  142. 142.
    Whitlatch, LW, Young, MV, Schwartz, GG,  et al. 200225-hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transferJ Steroid Biochem Mol Biol.81135140CrossRefPubMedGoogle Scholar
  143. 143.
    Ma, JF, Nonn, L, Campbell, MJ,  et al. 2004Mechanisms of decreased vitamin D 1alpha-hydroxylase activity in prostate cancer cellsMol Cell Endocrinol.2216774CrossRefPubMedGoogle Scholar
  144. 144.
    Tangpricha, V, Flanagan, JN, Whitlatch, LW,  et al. 200125-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissueLancet.35716731674CrossRefPubMedGoogle Scholar
  145. 145.
    Cross, HS, Bareis, P, Hofer, PH,  et al. 200125-hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesisSteroids.66287292CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Channing Laboratory, Department of MedicineHarvard Medical School and Brigham and Women’s HospitalBoston
  2. 2.Department of NutritionHarvard School of Public HealthBoston
  3. 3.Department of EpidemiologyHarvard School of Public HealthBostonUSA

Personalised recommendations